![](/img/cover-not-exists.png)
Should antithrombotic therapy be different in patients with atrial fibrillation and a so-called temporary cause and especially after an acute coronary syndrome?
Fauchier, L., Bisson, A., Clementy, N., Pierre, B., André, C., Angoulvant, D., Babuty, D., Lip, GYH.Volume:
11
Journal:
Archives of Cardiovascular Diseases Supplements
DOI:
10.1016/j.acvdsp.2018.10.262
Date:
January, 2019
File:
PDF, 220 KB
2019